Our final episode concludes with a discussion with a clinical trials researcher and a patient advocate about how metastatic disease has changed and where it’s headed. They will discuss the exciting frontiers of research, clinical trials and the future of treatment. The panel will also highlight the ways that the metastatic community has come together to organize, support and speak out for the well-being of metastatic patients.
"Let’s Talk Metastatic Breast Cancer” is an eight-part series of 30-minute webinars that brought together metastatic patients, their doctors, researchers and social workers to explore the challenges of being a metastatic breast cancer patient.
The series is structured around the chronology of the patient's journey. We began with the moment of diagnosis, then on through prognosis and treatment while touching on the tribulations that metastatic disease poses to everyday lives. How does breast cancer affect working, caregiving and intimacy? We joined with experts to help us understand the future, both medically and personally, for life with metastatic disease. What are today’s clinical trials all about? How is the world of the metastatic patient evolving? “Let’s Talk Metastatic Breast Cancer” offers metastatic patients the information and resources they’re looking for, and the sense of community that is so important.
This program is sponsored by Seattle Genetics. This organization has no editorial control. It is produced by Patient Power, and Patient Power is solely responsible for program content.
Already have an account? Login and register
Friday, June 12, 2020
With the coronavirus pandemic, has research on myeloproliferative neoplasms (MPNs) halted? Are clinical trials still moving forward? Join us for a live Answers Now program on Friday, June 12th at 1 pm PT/4 pm ET as host and MPN patient Andrew Schorr talks to two MPN researchers, Dr.
Tuesday, June 16, 2020
"Who is at risk for metastatic breast cancer?" "Is metastatic disease genetic or environmental?" "How does it occur in the body?" Get the answers to these questions during part two of our Let's Talk About Metastatic Breast Cancer series.
Tuesday, July 21, 2020
Usually patients take the tests and receive the results, but what do the doctors see, and how do they interpret the tests? How is metastatic disease usually identified? This week, our guests include an oncologist and a radiologist who explain how scans and blood tests confirm an MBC diagnosis.